2m 2m 2m 2m 2m 2m 2m
Atricure (ATRC)
NASDAQ
$28.20-$0.24 (-0.84%)
Price as of Jun 23, 2026 4:19 PM EDT- $1.4BMarket Cap
- -10.85%1-Year Change
- Medical Instruments & SuppliesIndustry
Atricure (ATRC)
$28.20-$0.24 (-0.84%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 534.5M +14.88% | 465.3M +16.55% | 399.2M +20.84% | 330.4M +20.43% | |
Cost of Revenue | 133.7M +13.56% | 117.8M +19.12% | 98.9M +17.10% | 84.4M +23.32% | |
Gross Profit | 400.8M +15.32% | 347.5M +15.70% | 300.4M +22.13% | 245.9M +19.47% | |
Sales and Marketing Expense | 311.0M +6.75% | 291.4M +15.10% | 253.1M +9.45% | 231.3M +13.01% | |
Research and Development Expense | -99.2M +3.15% | -96.2M +30.12% | -73.9M +28.91% | -57.3M +18.21% | |
Depreciation and Amortization Expense | 8.4M +12.26% | 7.5M +40.46% | 5.4M +46.54% | 3.7M +25.66% | |
Total Operating Expenses | 410.2M +5.85% | 387.5M +18.49% | 327.1M +13.32% | 288.6M +91.57% | |
Operating Profit | -9.4M -76.39% | -40.0M +49.96% | -26.7M -37.47% | -42.7M -177.29% | |
Interest Income | 4.5M +1.01% | 4.4M +16.93% | 3.8M +90.17% | 2.0M +327.90% | |
Interest Expense | N/A N/A | N/A N/A | -6.9M +38.89% | -5.0M +1.38% | |
Interest Income and Expense and Net | 4.5M +1.01% | 4.4M +241.53% | -3.1M +4.71% | -3.0M -32.79% | |
Total Nonoperating Income and Expense | 683,000 +309.51% | -326,000 +951.61% | -31,000 -94.23% | -537,000 +46.72% | |
Income before Taxes | -10.2M -76.73% | -43.7M +46.33% | -29.8M -35.39% | -46.2M -191.69% | |
Income Taxes | 1.3M +25.49% | 1.0M +73.27% | 591,000 +120.52% | 268,000 +42.55% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.4M -74.39% | -44.7M +46.85% | -30.4M -34.49% | -46.5M -192.56% | |
Net Income from Continuing Operations Applicable to Common | -10.2M -76.73% | -43.7M +46.33% | -29.8M -35.39% | -46.2M -191.69% | |
Basic EPS and Net Income | -0.24 -74.74% | -0.95 +43.94% | -0.66 -35.29% | -1.02 -191.89% | |
Diluted EPS and Net Income | -0.24 -74.74% | -0.95 +43.94% | -0.66 -35.29% | -1.02 -193.58% | |
Basic Weighted Average Shares | 47.8M +1.67% | 47.0M +1.42% | 46.3M +1.24% | 45.7M +1.50% | |
Diluted Weighted Average Shares | 47.8M +1.67% | 47.0M +1.42% | 46.3M +1.24% | 45.7M -0.65% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 167.4M +36.43% | 122.7M +45.56% | 84.3M +45.11% | 58.1M +33.09% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 53.0M -15.93% | 63.0M -16.47% | |
Cash and Cash Equivalents and Short-Term Investments | 167.4M +36.43% | 122.7M -10.61% | 137.3M +13.35% | 121.1M +1.70% | |
Total Current Assets | 322.5M +20.42% | 267.8M +0.59% | 266.2M +23.71% | 215.2M +9.76% | |
Accumulated Depreciation | 69.8M +13.82% | 61.3M +16.92% | 52.4M +11.97% | 46.8M +13.45% | |
Property and Plant and Equipment and Net | 39.1M -6.09% | 41.7M -1.83% | 42.4M +9.28% | 38.8M +23.64% | |
Total Long-Term Assets | 2.9M -0.14% | 2.9M +32.78% | 2.2M +8.82% | 2.0M +107.85% | |
Total Assets | 654.2M +7.36% | 609.3M -0.75% | 613.9M +4.87% | 585.4M -4.85% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 865,000 -69.16% | 2.8M +10.74% | 2.5M -91.56% | 30.0M 0.00% | |
Total Current Liabilities | 81.5M +11.03% | 73.4M -1.54% | 74.6M +27.70% | 58.4M +3.45% | |
Total Long-Term Debt | 61.9M 0.00% | 61.9M +2.10% | 60.6M +6.61% | 56.8M -4.87% | |
Total Long-Term Liabilities | 7.3M +506.86% | 1.2M -1.94% | 1.2M +0.65% | 1.2M +0.49% | |
Total Liabilities | 162.2M +9.36% | 148.4M +0.40% | 147.8M +14.82% | 128.7M -2.18% | |
Retained Earnings | -413.2M +2.85% | -401.8M +12.52% | -357.1M +9.32% | -326.6M +16.59% | |
Total Stockholders Equity | 491.9M +6.72% | 461.0M -1.12% | 466.2M +2.06% | 456.8M -5.58% | |
Total Shares Outstanding | 49.8M +1.89% | 48.9M +2.83% | 47.5M +2.07% | 46.6M +1.19% | |
Cash Flow | |||||
Cash from Operating Activities | 57.3M +369.80% | 12.2M +172.17% | 4.5M +120.25% | -22.1M +60.67% | |
Capital Expenditures | 9.1M -21.02% | 11.5M -4.49% | 12.0M -28.93% | 16.9M +73.09% | |
Cash from Investing Activities | -14.6M -148.12% | 30.2M +38.58% | 21.8M -50.42% | 44.0M +87.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.2M +132.64% | -3.6M +11,159.38% | -32,000 -99.55% | -7.1M -7.63% | |
Financials Ratio | |||||
Gross Margin | 74.98% +0.39% | 74.69% -0.73% | 75.23% +1.06% | 74.44% -0.80% | |
Operating Margin | -1.77% -79.45% | -8.60% +28.67% | -6.68% -48.25% | -12.92% -164.18% | |
Return on Assets | -1.81% -75.20% | -7.31% +43.98% | -5.08% -34.42% | -7.74% -202.51% | |
Return on Equity | -2.40% -75.08% | -9.64% +46.18% | -6.60% -33.25% | -9.88% -188.20% | |
Revenue Growth | 14.88% -10.09% | 16.55% -20.62% | 20.84% +2.02% | 20.43% -37.76% | |
Current Ratio | 3.96 +8.46% | 3.65 +2.16% | 3.57 -3.13% | 3.69 +6.10% | |
Cash Ratio | 2.05 +22.88% | 1.67 +47.83% | 1.13 +13.63% | 1.00 +28.65% | |
Debt-to-Equity Ratio | 0.13 -9.12% | 0.14 +3.62% | 0.14 -28.77% | 0.19 +2.48% | |
Debt-to-Assets Ratio | 0.10 -9.61% | 0.11 +3.21% | 0.10 -30.68% | 0.15 +1.71% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow